HomeNGENF • OTCMKTS
add
NervGen Pharma Corp
Previous close
$1.55
Day range
$1.48 - $1.58
Year range
$1.17 - $2.99
Market cap
149.04M CAD
Avg Volume
47.93K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.00M | 25.80% |
Net income | -7.83M | -64.34% |
Net profit margin | — | — |
Earnings per share | -0.11 | — |
EBITDA | -5.99M | -26.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.56M | 65.15% |
Total assets | 27.89M | 60.14% |
Total liabilities | 15.40M | 56.24% |
Total equity | 12.49M | — |
Shares outstanding | 70.18M | — |
Price to book | 8.61 | — |
Return on assets | -50.28% | — |
Return on capital | -94.81% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -7.83M | -64.34% |
Cash from operations | -4.18M | -109.18% |
Cash from investing | 8.41K | 385.70% |
Cash from financing | 111.28K | -56.17% |
Net change in cash | -3.74M | -93.12% |
Free cash flow | 104.13K | 125.08% |
About
Founded
2017
Headquarters
Website
Employees
10
